172 filings
Page 6 of 9
8-K
7h1i6z7npxnfa 9crgxh
12 Oct 18
Trevena Announces Oliceridine FDA Advisory Committee Meeting Outcome
7:00am
8-K
ie6yf4cc63qdx9h0pvau
11 Oct 18
Regulation FD Disclosure
7:00am
8-K
ctald 7b9
1 Oct 18
Trevena announces completion of leadership transition and appointment of new director
4:29pm
8-K
n67lt
2 Aug 18
Trevena Reports Second Quarter 2018 Financial Results
7:03am
8-K
m516o
15 Jun 18
Entry into a Material Definitive Agreement
4:59pm
8-K
mek9flq4eczemg6
13 Jun 18
Departure of Directors or Certain Officers
12:00am
8-K
wquqp
21 May 18
Amendments to Articles of Incorporation or Bylaws
4:02pm
8-K
z8i0clxt
3 May 18
Trevena Reports First Quarter 2018 Financial Results
12:00am
8-K
plpgast
12 Apr 18
Departure of Directors or Certain Officers
12:00am
8-K
79vpv7med4e59ggddad
6 Apr 18
Departure of Directors or Certain Officers
12:00am
8-K
nrowu09lh uassg5
7 Mar 18
Trevena Reports Full Year 2017 Earnings
12:00am
8-K
kgyjphvfbnu 05sj
2 Mar 18
Entry into a Material Definitive Agreement
12:00am
8-K
8386ob
2 Feb 18
Departure of Directors or Certain Officers
12:00am
8-K
ovgu4gh45xnkn1exw
5 Jan 18
Trevena Announces FDA Acceptance for Review of New
12:00am
8-K
87z1x pp0
7 Nov 17
Trevena Reports Third Quarter 2017 Financial Results and Announces New Positive Clinical Trial Data
12:00am
8-K
2seeg kg50ht
13 Oct 17
Trevena Announces Restructuring to Focus Resources on Commercial Strategy
12:00am
8-K
u0kvw7
3 Aug 17
Trevena Reports Second Quarter 2017 Financial Results and Provides Corporate Update
12:00am
8-K
b1lf8w09w57clrv yl0
16 Jun 17
Entry into a Material Definitive Agreement
12:00am
8-K
3cqbag42691tzfny8y
19 May 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
0ka 3rgyobims47nq
4 May 17
Trevena Reports First Quarter 2017 Financial Results and Provides Corporate Update
12:00am